Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

468 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Variation of breast cancer risk among BRCA1/2 carriers.
Begg CB, Haile RW, Borg A, Malone KE, Concannon P, Thomas DC, Langholz B, Bernstein L, Olsen JH, Lynch CF, Anton-Culver H, Capanu M, Liang X, Hummer AJ, Sima C, Bernstein JL. Begg CB, et al. Among authors: lynch cf. JAMA. 2008 Jan 9;299(2):194-201. doi: 10.1001/jama.2007.55-a. JAMA. 2008. PMID: 18182601 Free PMC article.
Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study.
Figueiredo JC, Haile RW, Bernstein L, Malone KE, Largent J, Langholz B, Lynch CF, Bertelsen L, Capanu M, Concannon P, Borg A, Børresen-Dale AL, Diep A, Teraoka S, Torngren T, Xue S, Bernstein JL. Figueiredo JC, et al. Among authors: lynch cf. Breast Cancer Res Treat. 2010 Feb;120(1):175-83. doi: 10.1007/s10549-009-0455-5. Epub 2009 Jul 14. Breast Cancer Res Treat. 2010. PMID: 19597986 Free PMC article.
Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer.
Reding KW, Bernstein JL, Langholz BM, Bernstein L, Haile RW, Begg CB, Lynch CF, Concannon P, Borg A, Teraoka SN, Törngren T, Diep A, Xue S, Bertelsen L, Liang X, Reiner AS, Capanu M, Malone KE; WECARE Collaborative Study Group. Reding KW, et al. Among authors: lynch cf. Breast Cancer Res Treat. 2010 Sep;123(2):491-8. doi: 10.1007/s10549-010-0769-3. Epub 2010 Feb 5. Breast Cancer Res Treat. 2010. PMID: 20135344 Free PMC article.
Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.
Bernstein JL, Haile RW, Stovall M, Boice JD Jr, Shore RE, Langholz B, Thomas DC, Bernstein L, Lynch CF, Olsen JH, Malone KE, Mellemkjaer L, Borresen-Dale AL, Rosenstein BS, Teraoka SN, Diep AT, Smith SA, Capanu M, Reiner AS, Liang X, Gatti RA, Concannon P; WECARE Study Collaborative Group. Bernstein JL, et al. Among authors: lynch cf. J Natl Cancer Inst. 2010 Apr 7;102(7):475-83. doi: 10.1093/jnci/djq055. Epub 2010 Mar 19. J Natl Cancer Inst. 2010. PMID: 20305132 Free PMC article.
Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.
Malone KE, Begg CB, Haile RW, Borg A, Concannon P, Tellhed L, Xue S, Teraoka S, Bernstein L, Capanu M, Reiner AS, Riedel ER, Thomas DC, Mellemkjaer L, Lynch CF, Boice JD Jr, Anton-Culver H, Bernstein JL. Malone KE, et al. Among authors: lynch cf. J Clin Oncol. 2010 May 10;28(14):2404-10. doi: 10.1200/JCO.2009.24.2495. Epub 2010 Apr 5. J Clin Oncol. 2010. PMID: 20368571 Free PMC article.
Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status.
Figueiredo JC, Brooks JD, Conti DV, Poynter JN, Teraoka SN, Malone KE, Bernstein L, Lee WD, Duggan DJ, Siniard A, Concannon P, Capanu M, Lynch CF, Olsen JH, Haile RW, Bernstein JL. Figueiredo JC, et al. Among authors: lynch cf. Breast Cancer Res Treat. 2011 Jun;127(3):819-29. doi: 10.1007/s10549-010-1285-1. Epub 2010 Dec 15. Breast Cancer Res Treat. 2011. PMID: 21161372 Free PMC article.
Body mass index and risk of second primary breast cancer: the WECARE Study.
Brooks JD, John EM, Mellemkjær L, Reiner AS, Malone KE, Lynch CF, Figueiredo JC, Haile RW, Shore RE; WECARE Study Collaborative Group; Bernstein JL, Bernstein L. Brooks JD, et al. Among authors: lynch cf. Breast Cancer Res Treat. 2012 Jan;131(2):571-80. doi: 10.1007/s10549-011-1743-4. Epub 2011 Sep 3. Breast Cancer Res Treat. 2012. PMID: 21892703 Free PMC article.
Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study.
Brooks JD, Teraoka SN, Reiner AS, Satagopan JM, Bernstein L, Thomas DC, Capanu M, Stovall M, Smith SA, Wei S, Shore RE, Boice JD Jr, Lynch CF, Mellemkjaer L, Malone KE, Liang X; Wecare Study Collaborative Group; Haile RW, Concannon P, Bernstein JL. Brooks JD, et al. Among authors: lynch cf. Hum Mutat. 2012 Jan;33(1):158-64. doi: 10.1002/humu.21604. Epub 2011 Sep 29. Hum Mutat. 2012. PMID: 21898661 Free PMC article.
Variation in genes related to obesity, weight, and weight change and risk of contralateral breast cancer in the WECARE Study population.
Brooks JD, Bernstein L, Teraoka SN, Knight JA, Mellemkjær L, John EM, Malone KE, Reiner AS, Lynch CF, Concannon P, Haile RW, Bernstein JL; WECARE Study Collaborative Group. Brooks JD, et al. Among authors: lynch cf. Cancer Epidemiol Biomarkers Prev. 2012 Dec;21(12):2261-7. doi: 10.1158/1055-9965.EPI-12-1036. Epub 2012 Oct 2. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 23033454 Free PMC article.
468 results